Skip to main content

Yigal Nochomovitz

Stock Analyst at Summit Redstone Partners

Total Price Targets
10
Stocks Covered
9
Sectors
Healthcare
Most Recent
Mar 26, 2025

Stocks Covered by Yigal Nochomovitz

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
SMMTSummit Therapeutics Inc.$35.00$16.11+117.3%2Mar 26, 2025
RCUSArcus Biosciences, Inc.$46.00$25.66+79.3%1Oct 24, 2024
AVBPArriVent BioPharma, Inc. Common Stock$36.00$30.55+17.8%1Sep 10, 2024
IDYAIDEAYA Biosciences, Inc.$58.00$28.27+105.2%1Aug 27, 2024
STTKShattuck Labs, Inc.$8.00$7.00+14.3%1Aug 15, 2024
LENZLENZ Therapeutics, Inc.$32.00$8.85+261.8%1Aug 15, 2024
SNDXSyndax Pharmaceuticals, Inc.$34.00$19.18+77.3%1Aug 15, 2024
FATEFate Therapeutics, Inc.$87.00$1.55+5494.9%1Nov 8, 2021
RAREUltragenyx Pharmaceutical Inc.$150.00$24.79+505.2%1Nov 3, 2021

Recent Activity

  • Mar 26, 2025— Set$35.00price target onSMMT(Summit Therapeutics Inc.)
  • Oct 24, 2024— Set$46.00price target onRCUS(Arcus Biosciences, Inc.)
  • Sep 27, 2024— Set$23.00price target onSMMT(Summit Therapeutics Inc.)
  • Sep 10, 2024— Set$36.00price target onAVBP(ArriVent BioPharma, Inc. Common Stock)
  • Aug 27, 2024— Set$58.00price target onIDYA(IDEAYA Biosciences, Inc.)
  • Aug 15, 2024— Set$32.00price target onLENZ(LENZ Therapeutics, Inc.)
  • Aug 15, 2024— Set$34.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
  • Aug 15, 2024— Set$8.00price target onSTTK(Shattuck Labs, Inc.)
  • Nov 8, 2021— Set$87.00price target onFATE(Fate Therapeutics, Inc.)
  • Nov 3, 2021— Set$150.00price target onRARE(Ultragenyx Pharmaceutical Inc.)

Frequently Asked Questions

Who is Yigal Nochomovitz?

Yigal Nochomovitz is a stock analyst at Summit Redstone Partners covering 9 stocks primarily in Healthcare. They have issued 10 price targets since Nov 3, 2021.

What stocks does Yigal Nochomovitz cover?

Yigal Nochomovitz currently covers 9 stocks, including SMMT, RCUS, AVBP, IDYA, STTK.

What is Yigal Nochomovitz's latest price target?

Yigal Nochomovitz's most recent price target was $35.00 on SMMT (Summit Therapeutics Inc.), set on Mar 26, 2025.

What is Yigal Nochomovitz's highest price target?

Yigal Nochomovitz's highest issued price target is $150.00 on RARE, set on Nov 3, 2021.

Coverage based on publicly published price targets. Not investment advice.